Checkpoint inhibitors are drugs that block proteins which normally keep immune cells from attacking cancer cells. By inhibiting these checkpoint proteins, the immune system is better equipped to identify and destroy cancer cells. Examples include pembrolizumab (Keytruda) and nivolumab (Opdivo).